Changes in Preference for Surgery of Patients Signed up for Arthroscopic Procedures

Sponsor
Region Zealand (Other)
Overall Status
Completed
CT.gov ID
NCT04370678
Collaborator
(none)
79
1
7
343.5

Study Details

Study Description

Brief Summary

This study describes the changes in preference to arthroscopic surgery in two orthopedics departments in Denmark under the COVID-19 pandemic.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Change in preference to surgery under COVID-19 pandemic.

Detailed Description

Background:

Covid-19 has impacted all aspects of society. In hospitals around the world focus has been on treating the deadly virus, and elective orthopedic surgical procedures has been postponed in Denmark, causing a stop for most arthroscopic procedures for months. It is established that certain conditions leading to arthroscopic orthopedic intervention has fluctuating symptoms symptoms and can have a favorable outcome on conservative treatment. Amongst these conditions who are also treated with non-surgical methods are subacromial decompression impingement[1][1], degenerative knee disease [2] and anterior cruciate ligament injuries[3]. An issue with further understanding the non-surgical effect on this patient group has beencould be reluctance to undergo conservative non-surgical treatment and opt for a surgical treatment. procedure. Because all elective surgery has been postponed in Denmark, and the following longer waiting period for surgery, this has created a unique opportunity to further investigate this patient category.

Aim of study: Investigate the impact of time on waiting list for surgery under COVID-19 pandemic on the preference for surgery in patients planned for arthroscopic surgery.

Discussion The current study will provide information on the change of preferences forto arthroscopic surgery in a patient population who are forced to wait for surgery for a longer period of time, with no possibility of seeking treatment in other hospitals.

Study Design

Study Type:
Observational
Actual Enrollment :
79 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
Changes in Preference for Surgery of Patients Signed up for Arthroscopic Procedures: COVID-19 Effect on Arthroscopic Patients in a University Hospital in Denmark
Actual Study Start Date :
Apr 17, 2020
Actual Primary Completion Date :
Apr 24, 2020
Actual Study Completion Date :
Apr 24, 2020

Outcome Measures

Primary Outcome Measures

  1. Change in preference [3 months]

    change of preference for surgery during the waiting period for all planned arthroscopic procedures measured by questionnaire sent by letter asking if patients still want surgery yes or no. No other questions were asked.

Secondary Outcome Measures

  1. Change in preference between groups [3 months]

    difference in preference for surgery between the group of patients planned for arthroscopic procedure in the shoulder and patients planned for arthroscopic procedure in the knee measured by questionnaire sent by letter asking if patients still want surgery yes or no. No other questions were asked..

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Patients planned for arthroscopic intervention in knee or shoulder.

  • Patients seen by an orthopedic surgeon and planned for surgery before 13/3-20

Exclusion Criteria:
  • Surgery performed in another hospital

  • Death

  • Emigration

Contacts and Locations

Locations

Site City State Country Postal Code
1 Zealand University Hospital Køge Zealand Region Denmark 4600

Sponsors and Collaborators

  • Region Zealand

Investigators

  • Principal Investigator: Jesper S Nielsen, MD, Zealand University Hospital, Køge

Study Documents (Full-Text)

More Information

Publications

Responsible Party:
Jesper Nielsen, Principal investigator, Region Zealand
ClinicalTrials.gov Identifier:
NCT04370678
Other Study ID Numbers:
  • ArthrocancellationSUH2020
First Posted:
May 1, 2020
Last Update Posted:
May 7, 2020
Last Verified:
May 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jesper Nielsen, Principal investigator, Region Zealand

Study Results

No Results Posted as of May 7, 2020